Takeda sets path for first foreign CEO in 232-year history

Japan's Takeda Pharmaceutical (TKPHF) has named 20-year GlaxoSmithKline veteran Christophe Weber as the candidate to become its next CEO.

Assuming Takeda's shareholders approve the appointment of Weber, the French national is set to become the company's first non-Japanese leader in its 232-year history.

Weber, who is the president of GSK's vaccines division in Belgium, will become Takeda's COO by April, its president in June, and its CEO in 2015. (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs